| Name | Walgreens #19957 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 739 Greenwood Ave, Trenton, New Jersey 08609 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (609) 989-1299 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
House Democrats, led by Rep. Pramila Jayapal (D-Wash.), have formally introduced their "Medicare-for-all" legislation.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
| NPI Number | 1366966608 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #19957 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 739 Greenwood Ave, Trenton, NJ 08609 |
| Phone Number | 609-989-1299 |
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
House Democrats, led by Rep. Pramila Jayapal (D-Wash.), have formally introduced their "Medicare-for-all" legislation.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
| NPI Number | 1447369814 |
| Organization Name | RITE AID OF NEW JERSEY INC |
| Doing Business As | RITE AID PHARMACY 03258 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 739 Greenwood Avenue, Trenton, NJ 08609 |
| Phone Number | 609-989-1299 |
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
House Democrats, led by Rep. Pramila Jayapal (D-Wash.), have formally introduced their "Medicare-for-all" legislation.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
House Democrats, led by Rep. Pramila Jayapal (D-Wash.), have formally introduced their "Medicare-for-all" legislation.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
Breathe Rite Medical And Surgical E Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1285 S Broad St, Trenton, New Jersey 08610 Phone: (609) 394-2770 | |
Cvs Pharmacy # 02870 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1240 Greenwood Ave, Trenton, New Jersey 08609 Phone: (609) 394-2604 | |
Rite Aid Pharmacy #01326 Type: Pharmacy Location: 1801 Kuser Rd, Trenton, New Jersey 08690 Phone: (609) 585-3925 | |
Cvs Pharmacy #01967 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1100 Liberty St, Trenton, New Jersey 08611 Phone: (609) 599-9342 | |
Delcrest Medical Supplies Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2670 Nottingham Way, Trenton, New Jersey 08619 Phone: (609) 586-1679 |